(A–D) The generation of Kif2a-cKO mice. (A) Schematic diagram of the conditional Kif2a targeting strategy. The conventional targeting allele is also shown at the bottom. Tamoxifen-induced Cre …
The raw data of body weight, activity, and survival rate of WT and 3w-Kif2a-cKO mice.
(A–D) Electroencephalography (EEG) recordings. (A) Representative baseline EEG recordings of WT and 3w-Kif2a-cKO hippocampi in postnatal week 6. Some spikes were observed in the cKO brain, even in …
EEG recordings of WT and 3w-Kif2a-cKO mice.
The latency and lasted time of PDS occurred in the 3w-Kif2a-cKO hippocampal slices.
(A–D) The typical features of hippocampal sclerosis in 4w-Kif2a-cKO mice at postnatal week 12. The 4w-Kif2a-cKO mice clearly showed hippocampal atrophy (A), including CA1 loss (B), sprouting MFs in …
GFAP-positive area in WT and 3w-Kif2a-cKO dentate gyrus at P35.
This recording was obtained at postnatal week 5 in a mouse after an EEG operation at postnatal week 4. The epileptic convulsion continued throughout the video. The EEG wave for this convulsion is …
(A) The injection scheme of thymidine analogs and tamoxifen. CldU and IdU were injected during postnatal weeks 2 and 3, respectively. The mice were fixed and double-stained with anti-CldU and …
The migrating distance, direction, and expression of birth-dating marker of WT and 3w-Kif2a-cKO DGCs at P35.
(A–B) The expression of postnatal KIF2A in the hippocampus at P21. Note that KIF2A is highly expressed in the dentate hilus (Hil) and stratum lucidum (SL) (A) where DGCs extend their axons, termed …
Timm grain intensity in WT and 3w-Kif2a-cKO dentate gyrus at P35.
(A–D) Representative images showing Timm staining of the hippocampus at P35. C and D are magnified images of the areas indicated by the red rectangles in A and B. Coronal cryosections in the …
Timm grain intensity in CBZ-injected-WT and CBZ-injected-3w-Kif2a-cKO dentate gyrus at P35.
(A–B) Representative images of cryosections immunostained with anti-NFM and anti-MAP2 at P35. Images are 1-μm-thick confocal optical sections (OS). Compared with WT (A), 3w-Kif2a-cKO mice had more …
Intensity of NFM-staining in WT and 3w-Kif2a-cKO dentate gyrus at P35.
Intensity of synaptoporin-staining in WT and 3w-Kif2a-cKO dentate gyrus at P35.
(A) Schematics of unsolved questions in developing DGCs in the Kif2a-cKO dentate granule layer (DGL). In the postnatal hippocampus (left panel), DGCs continuously proliferated in the SGZ, migrated …
The population of the cells with apical axons in the outer ML, the cells with protrusion in the inner ML, and the ectopic cells in inner ML in WT and 3w-Kif2a-cKO dentate gyrus at P35.
The spine morphology of dendrites in IML and OML of WT and 3w-Kif2a-cKO dentate gyrus at P35.
(A–L) Representative images of dissociated cultured DGCs immunostained with an axon marker (NFM or Tau1) and a dendrite marker (MAP2) at DIV1 (A–H) and DIV5 (I–L). At DIV1, both WT DGCs (A–D) and …
The character of neuronal processes from a cell body of WT and P3-Kif2a-cKO DGCs.
(A–C) Characterization of dissociated cultured granule cells and confirmation of their loss of KIF2A. A-B. Representative images of cultured DGCs. Granule cells from the hippocampal dentate gyri of …
The number of Ankyrin G-positive processes from a cell body of of WT and P3-Kif2a-cKO DGCs at DIV3.
(A–G) The rescue experiment. (A–D) Representative images of single cultured DGCs. DGCs were transfected with YFP or YFP-KIF2A at DIV3 and then observed at DIV4. Compared with the WT DGCs (A), cKO …
This recording was obtained at the end of DIV2 for 8 hr. The DGC controls the length of an axon and a dendrite. No protrusions from the cell body. An immunostained image of the recorded cell is …
This recording was obtained at the end of DIV2 for 8 hr. The DGC is rapidly elongating and branching an axon and dendrites, in addition to some aberrant protrusions from the cell body. An …
(A) KIF2A function in DGC development. At the early stages of development, both WT and cKO DGCs normally make axonal and dendritic processes. However, whereas WT DGCs regulate the length of …
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Gene (Mus muscu/us) | Kif2a | PMID:1447303 | MGl:108390 | |
Strain, strain background (Mus muscu/us) | C57BU6NJcl, C57BU6JJcl | Clea Japan | ||
Strain, strain background(Mus muscu/us) | CreERt(CAG-cre/Esr1) | The Jackson Laboratory | Tg(CAG-cre/Esr1 *)5Amc/J (Stock No: 004453) | |
Strain, strain background(Mus muscu/us) | R26R (lacZ expression with the ROSA26 Cre reporter strain) | PMID:9916792 | ||
Strain, strain background(Mus muscu/us) | Thy1-EGFP line M | The Jackson Laboratory | Tg(Thy1-EGFP)MJrs/J (Stock No: 007788) | |
Cell line (Mus musculus) | CMTl-1 | Merck Millipore | 129/Sv-derived ES cell (ESC) line | |
Antibody | anti-KIF2A (mouse monoclonal) | PMID: 7535303 | (1:200) | |
Antibody | anti-KIF2A (rabbit polyclonal) | Thermo Fisher | Thermo Fisher: PA3-16833 | (1:1500) |
Antibody | anti-GFAP(mouse monoclonal) | BO Transduction Laboratory | BO Bioscience: 610565 (Clone 52/GFAP) | (1:200) |
Antibody | anti-BrdU (mouse monoclonal) for ldU | BO Pharmingen | BO Bioscience: 555627 (Clone 304) | (1:1000) |
Antibody | anti-BrdU (rat monoclonal) for CldU | Accurate Chemicals | Accurate Chemicals (Clone: BU1/75) | (1:500) |
Antibody | anti-Tau1 (mouse monoclonal) | Merck Millipore | Merck Millipore: MAB3410 (Clone PC1C6) | (1:1000) |
Antibody | anti-Neurofilament M (mouse monoclonal) | Sigma | Sigma: N5264 (Clone NN18) | (1:600) |
Antibody | anti-MAP2 (chicken monoclonal) | Abeam | Abeam: AB5392 (Clone 304) | (1:200) |
Antibody | anti-Synaptoporin (rabbit polyclonal) | Synapitic Systems | SYSY:102002 | (1:300) |
Antibody | anti-Prox1 (rabbit polyclonal) | Merck Millipore | Merck Millipore: AB5475 | (1:10000) |
Antibody | anti-Ankyrin G (mouse monoclonal) | Thermo Fisher | Thermo Fisher: 338800 (Clone 4G318) | (1:600) |
Antibody | Alexa 488-, 546-, 555-, 647, (Goat polyclonal) | Molecular Probes | (1: 200–1: 500) | |
Recombinant DNA reagent | pEYFP-C1 (vector) | Clontech | ||
Recombinant DNA reagent | YFP-Kif2a (full length) | PMID: 14980225 | Progenitors: pEYFP-C1 vector | |
Commercial assay or kit | LA PCR Kit | Takara | TaKaRa:RR013A | |
Chemical compound, drug | Tamoxifen | Sigma | Sigma:T5648 | (30 mg/kg body weight/day) |
Chemical compound, drug | Pilocarpine | Sigma | Sigma: P6503 | (290 mg/kg body weight/day}, |
Chemical compound, drug | Scopolamine methyl bromide | Sigma | sigma: 8502 | (1 mg/kg body weight/day) |
Chemical compound, drug | ScaleView | Olympus | ||
Chemical compound, drug | 5-iodo-2'-deoxyuridine | Sigma | Sigma: 17125 | 50 mg/kg |
Chemical compound, drug | 5-chloro-2 '-deoxyuridene | Sigma | Sigma: C6891 | 50 mg/kg |
Chemical compound, drug | poly-L-lysine | Sigma | Sigma: P-2636 | 100 mg/ml |
Chemical compound, drug | Laminin | lnvitrogen | lnvitrogen: 23017–015 | 25 µg/ml |
Software, algorithm | MicroMax 1. 3 | AccuScan Instrument | ||
Software, algorithm | Clampex 9.2 software | Axon Instruments | ||
Software, algorithm | IMARIS 7.2 | Bitplane:Zeiss | ||
Software, algorithm | lmageJ 1.51 hr | NIH | ||
Software, algorithm | SPSS V22 | IBM | ||
Machine | MicroMax Monitor | AccuScan Instruments | ||
Machine | Axopatch 1D amplifier | Axon Instruments |